Rituximab as salvage therapy for refractory chronic GVHD - PubMed (original) (raw)
. 2008 May;41(10):909-11.
doi: 10.1038/bmt.2008.12. Epub 2008 Feb 18.
- PMID: 18278073
- DOI: 10.1038/bmt.2008.12
Rituximab as salvage therapy for refractory chronic GVHD
M Mohty et al. Bone Marrow Transplant. 2008 May.
No abstract available
Similar articles
- Treatment of refractory chronic GVHD with rituximab: a GITMO study.
Zaja F, Bacigalupo A, Patriarca F, Stanzani M, Van Lint MT, Filì C, Scimè R, Milone G, Falda M, Vener C, Laszlo D, Alessandrino PE, Narni F, Sica S, Olivieri A, Sperotto A, Bosi A, Bonifazi F, Fanin R; GITMO (Gruppo Italiano Trapianto Midollo Osseo). Zaja F, et al. Bone Marrow Transplant. 2007 Aug;40(3):273-7. doi: 10.1038/sj.bmt.1705725. Epub 2007 Jun 4. Bone Marrow Transplant. 2007. PMID: 17549053 - Clinical utility of rituximab in chronic graft-versus-host disease.
Bates JS, Engemann AM, Hammond JM. Bates JS, et al. Ann Pharmacother. 2009 Feb;43(2):316-21. doi: 10.1345/aph.1L386. Epub 2009 Feb 3. Ann Pharmacother. 2009. PMID: 19193571 Review. - Treatment of chronic steroid-refractory graft-versus-host disease with low-dose rituximab.
von Bonin M, Oelschlägel U, Radke J, Stewart M, Ehninger G, Bornhauser M, Platzbecker U. von Bonin M, et al. Transplantation. 2008 Sep 27;86(6):875-9. doi: 10.1097/TP.0b013e318183f662. Transplantation. 2008. PMID: 18813113 - Daclizumab has poor efficacy in steroid-refractory severe acute graft-versus-host disease: a single centre experience with 12 allograft patients.
Hui CH, Sia H, Mangos H, Horvath N, Lee H, Lewis I, Hughes T, To LB, Bardy P. Hui CH, et al. Bone Marrow Transplant. 2008 Feb;41(4):409-10. doi: 10.1038/sj.bmt.1705927. Epub 2007 Nov 19. Bone Marrow Transplant. 2008. PMID: 18026147 No abstract available. - Clinical applications of rituximab in allogeneic stem cell transplantation: anti-tumor and immunomodulatory effects.
Ratanatharathorn V, Pavletic S, Uberti JP. Ratanatharathorn V, et al. Cancer Treat Rev. 2009 Dec;35(8):653-61. doi: 10.1016/j.ctrv.2009.07.004. Epub 2009 Aug 13. Cancer Treat Rev. 2009. PMID: 19682801 Review.
Cited by
- Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies.
Tomaszewska A, Jagasia M, Beohou E, van der Werf S, Blaise D, Kanfer E, Milpied N, Reményi P, Ciceri F, Bourhis JH, Chevallier P, Solano C, Socié G, Bruno B, Rambaldi A, Castagna L, Kröger N, Corradini P, Afanasyev B, Ladetto M, Niederwieser D, Scheid C, Sengeloev H, Kroschinsky F, Yakoub-Agha I, Schoemans H, Koenecke C, Penack O, Perić Z, Greinix H, Duarte RF, Basak GW. Tomaszewska A, et al. Front Immunol. 2021 Feb 2;11:613954. doi: 10.3389/fimmu.2020.613954. eCollection 2020. Front Immunol. 2021. PMID: 33603743 Free PMC article. - Modifying Graft-versus-Host Disease in a Humanized Mouse Model by Targeting Macrophages or B-Cells.
Hogenes MCH, van Dorp S, van Kuik J, Monteiro FRP, Ter Hoeve N, Guedes L, van Dijk MR, Martens AC, de Weger RA. Hogenes MCH, et al. J Immunol Res. 2019 May 8;2019:3538963. doi: 10.1155/2019/3538963. eCollection 2019. J Immunol Res. 2019. PMID: 31205954 Free PMC article. - The Role of B Cell Targeting in Chronic Graft-Versus-Host Disease.
Rhoades R, Gaballa S. Rhoades R, et al. Biomedicines. 2017 Oct 17;5(4):61. doi: 10.3390/biomedicines5040061. Biomedicines. 2017. PMID: 29039818 Free PMC article. Review. - Biology of chronic graft-_vs_-host disease: Immune mechanisms and progress in biomarker discovery.
Presland RB. Presland RB. World J Transplant. 2016 Dec 24;6(4):608-619. doi: 10.5500/wjt.v6.i4.608. World J Transplant. 2016. PMID: 28058210 Free PMC article. Review. - Autoimmune-like hepatitis after allogeneic hematopoietic stem cell transplantation: humoral hepatic GvHD.
Koyama D, Ito M, Yokohata E, Watakabe K, Onodera K, Goto T, Seto A, Watanabe K, Doisaki M, Ozawa Y, Yamaguchi T, Miyamura K. Koyama D, et al. Bone Marrow Transplant. 2017 Jan;52(1):151-153. doi: 10.1038/bmt.2016.202. Epub 2016 Aug 15. Bone Marrow Transplant. 2017. PMID: 27526287 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources